Pharmaceutical News

RSS

Older patients drive more safely after surgery and anesthesia care

A study presented at ANESTHESIOLOGY 2011 found that older patients drove more safely than their younger counterparts after surgery and anesthesia care at an ambulatory surgery facility.

18 Oct 2011

Hypertension drugs might reduce occurrence of Alzheimer's

Within the next 20 years it is expected the number of people with Alzheimer's disease (AD) will double from its current figure of half a million to one million. A new study has looked at whether certain types of drugs used to treat high blood pressure, also called hypertension, might have beneficial effects in reducing the number of new cases of Alzheimer's disease each year.

18 Oct 2011

Obese children require much smaller doses of anesthetic propofol

A study presented at ANESTHESIOLOGY 2011 this week found that obese children required much smaller doses of the anesthetic propofol than non-obese children to bring about a safe level of unconsciousness.

18 Oct 2011

Accera identifies genetic profile of AD patients with heightened response to Axona

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.

18 Oct 2011

AHRQ: Asthma drug usage among children doubles

The proportion of children who used a prescribed controller drug to treat their asthma doubled from 29 percent in 1997-1998 to 58 percent in 2007-2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Oct 2011

HSV1 drugs could slow progression of Alzheimer's disease

Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer's disease (AD), a new study shows.

From The University of Manchester 18 Oct 2011

Nearly 30% of homes with young children have acetaminophen products stored unsafely

Nearly 30 percent of homes with young children have acetaminophen products stored unsafely, and nearly all homes included at least one expired medication, according to a research abstract presented Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.

18 Oct 2011

VIVUS announces Qnexa NDA resubmission for treatment of obesity

VIVUS, Inc. today announced that the company has resubmitted the New Drug Application (NDA) for Qnexa to the U.S. Food and Drug Administration.

18 Oct 2011

Inhaled anesthetics do not increase incidence of postoperative delirium

A study presented at ANESTHESIOLOGY 2011 in Chicago this week offered firm evidence that commonly used inhaled anesthetics such as isoflurane do not increase the incidence of postoperative delirium, which can affect how well some patients recover after surgery.

18 Oct 2011

MRI scans may become useful tools for assessing cholesterol drugs

MRI scanning could become a powerful new tool for assessing how well cholesterol drugs are working, according to Loyola University Health System cardiologist Binh An P. Phan, MD.

15 Oct 2011

New onset tenderness after combo hormone therapy increases risk of breast cancer

Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has shown.

15 Oct 2011

Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme

Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer patients, today announced the achievement of pre-clinical milestones in its alliance with GlaxoSmithKline (GSK), triggering $4 million in milestone payments.

15 Oct 2011

Watson confirms patent challenge of generic Daytrana

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.

15 Oct 2011

Brain scans can evaluate new treatments for attention deficit disorder

Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder. Working in mice, researchers at Washington University School of Medicine in St. Louis showed that they can use brain scans to quickly test whether drugs increase levels of a brain chemical known as dopamine.

15 Oct 2011

NextBio predicts mechanisms underlying drug toxicity and identifies new cancer biomarker

New research presented this week highlights the ability of NextBio to help life scientists and clinicians investigate publicly available genomic data to assess biological mechanisms underlying drug toxicity, as well as discover prospective cancer biomarkers for further validation.

15 Oct 2011

ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload

The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.

15 Oct 2011

Penn scientist tracks attitudes and H1N1 vaccination rates on Twitter

A unique and innovative analysis of how social media can affect the spread of a disease has been designed and implemented by a scientist at Penn State University studying attitudes toward the H1N1 vaccine. Marcel Salath-, an assistant professor of biology, studied how users of Twitter -- a popular microblogging and social-networking service -- expressed their sentiments about a new vaccine.

14 Oct 2011

IRMS tracks course of designer 'legal high' drugs manufacture

Urgently needed tests which could help identify the manufacturers of designer 'legal high' drugs are being developed in research led at the University of Strathclyde in Glasgow.

14 Oct 2011

Scientists conclude pesticide contamination as a major problem in Europe

Pesticides are a bigger problem than had long been assumed. This is the conclusion of a study in which scientists analysed data on 500 organic substances in the basins of four major European rivers. It was revealed that 38 per cent of these chemicals are present in concentrations which could potentially have an effect on organisms.

14 Oct 2011

Survey analyses management of patients suffering from EGFRI toxicities

A recent survey of nurses from seven European countries, published in the peer-reviewed journal ecancermedicalscience, has analysed the management of patients suffering from toxicities due to treatment with epidermal growth factor receptor inhibitors.

14 Oct 2011